U.C.L.A. Rheumatology Pathophysiology of Disease Course Lecture, Second Year Medical School 2005 |
|||||||||||||||||||||||||||||||||
Page 35 | |||||||||||||||||||||||||||||||||
......Index Go to Previous page .....Go to Next page | |||||||||||||||||||||||||||||||||
Biologic Response Modifiers and the Innate Immune Response Part VI (Etanercept (Enbrel), Tumor Necrosis Factor Receptor (TNF) and a 3D Model Page 35 |
|||||||||||||||||||||||||||||||||
Windows Media Player |
QuickTime Media Player |
Real Media Player |
|||||||||||||||||||||||||||||||
A 3d model of etanercept is shown and its mode of action is demonstrated. |
Animation: Etanercept 3d Model : A 3d model of etanercept is shown and its mode of action is demonstrated. |
Animation: Etanercept 3d Model : A 3d model of etanercept is shown and its mode of action is demonstrated. |
Animation:Etanercept 3d Model : A 3d model of etanercept is shown and its mode of action is demonstrated. |
||||||||||||||||||||||||||||||
Slide 1: "Tumor Necrosis Factor (TNF), the TNF Receptor, and a Linear Model of Etanercept (Enbrel) is Shown with the lipid Membrane Removed " 360 x 240 pixels 12kb drawn freehand in 3dStudio Max | Slide 2: "A more three Dimensional Design (Model) for Etanercept (Enbrel) is shown " 360 x 240 pixels 15kb drawn freehand in 3dStudio Max | Slide 3: "TNF and Etanercept about to Bind " 360 x 240 pixels 7kb drawn freehand in 3dStudio Max | |||||||||||||||||||||||||||||||
Click Picture or here for larger slides (720 x 480 ) 31kb | Click Picture or here for larger slides (720 x 480 ) 38kb | Click Picture or here for larger slides (720 x 480 ) 17kb | |||||||||||||||||||||||||||||||
Tumor necrosis factor (TNF) and the endothelial cells TNF receptors are shown with the other lipid membrane structures removed. The linear construct of etanercept is replaced by a model with a more three dimensional design. The interaction of TNF with etanercept is shown. etanercept, infliximab, and adalimumab all work by sopping up TNF in the body fluids. The significant response of RA to various treatments tells us a lot about its pathophysiology. Clearly, excess proinflammatory mediators, such as tumor necrosis factor (TNF), are playing a profound role, as shown by effectiveness of the BRMs. |
|||||||||||||||||||||||||||||||||
Page 35 | |||||||||||||||||||||||||||||||||
Slide 4: "Etanercept (Enbrel) Binds to Tumor Necrosis Factor (TNF) " 360 x 240 pixels 11kb drawn freehand in 3dStudio Max ax | |||||||||||||||||||||||||||||||||
......Index Go to Previous page .....Go to Next page | |||||||||||||||||||||||||||||||||
Click Picture or here for larger slides (720 x480 ) 29kb | |||||||||||||||||||||||||||||||||
About Us | Contact Us | ©2005 | This web site has been developed and maintained by Craig W. Wiesenhutter, M.D. | ||||||||||||||||||||||||||||||||